| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| Pathway | WP_AMINO_ACID_METABOLISM | 6.08e-04 | 91 | 6 | 2 | M39570 | |
| Pathway | WP_AMINO_ACID_METABOLISM | 7.05e-04 | 98 | 6 | 2 | MM15942 | |
| Pathway | REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION | 6.36e-03 | 299 | 6 | 2 | MM15711 | |
| Pathway | REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION | 6.73e-03 | 308 | 6 | 2 | M1070 | |
| Pathway | REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION | 8.30e-03 | 343 | 6 | 2 | MM15712 | |
| Pathway | REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION | 1.02e-02 | 381 | 6 | 2 | M1066 | |
| Pubmed | 7.21e-05 | 1139 | 8 | 4 | 36417873 | ||
| Interaction | ECI2 interactions | 6.40e-06 | 116 | 7 | 3 | int:ECI2 | |
| Interaction | MCCC2 interactions | 1.74e-05 | 162 | 7 | 3 | int:MCCC2 | |
| Interaction | ECH1 interactions | 6.59e-05 | 253 | 7 | 3 | int:ECH1 | |
| Interaction | KIF5B interactions | 1.70e-04 | 348 | 7 | 3 | int:KIF5B | |
| Interaction | FOXRED1 interactions | 2.06e-04 | 64 | 7 | 2 | int:FOXRED1 | |
| Interaction | MMUT interactions | 2.13e-04 | 65 | 7 | 2 | int:MMUT | |
| Interaction | RPL22 interactions | 3.39e-04 | 440 | 7 | 3 | int:RPL22 | |
| Interaction | MED30 interactions | 3.56e-04 | 84 | 7 | 2 | int:MED30 | |
| Interaction | DHRS2 interactions | 4.36e-04 | 93 | 7 | 2 | int:DHRS2 | |
| Interaction | SIRT3 interactions | 4.36e-04 | 93 | 7 | 2 | int:SIRT3 | |
| Interaction | ABHD10 interactions | 5.14e-04 | 101 | 7 | 2 | int:ABHD10 | |
| Interaction | MED10 interactions | 5.24e-04 | 102 | 7 | 2 | int:MED10 | |
| Interaction | OTC interactions | 5.45e-04 | 104 | 7 | 2 | int:OTC | |
| Interaction | RARS2 interactions | 5.55e-04 | 105 | 7 | 2 | int:RARS2 | |
| Interaction | FBXL19 interactions | 5.66e-04 | 106 | 7 | 2 | int:FBXL19 | |
| Interaction | MED19 interactions | 5.66e-04 | 106 | 7 | 2 | int:MED19 | |
| Interaction | MTHFD2 interactions | 6.09e-04 | 110 | 7 | 2 | int:MTHFD2 | |
| Interaction | NCCRP1 interactions | 6.20e-04 | 111 | 7 | 2 | int:NCCRP1 | |
| Interaction | H3-3B interactions | 6.54e-04 | 114 | 7 | 2 | int:H3-3B | |
| Interaction | TOP3A interactions | 6.54e-04 | 114 | 7 | 2 | int:TOP3A | |
| Coexpression | LANDIS_ERBB2_BREAST_PRENEOPLASTIC_DN | 1.29e-04 | 57 | 8 | 2 | M13447 | |
| Coexpression | LANDIS_ERBB2_BREAST_PRENEOPLASTIC_DN | 1.29e-04 | 57 | 8 | 2 | MM1094 | |
| Coexpression | LANDIS_ERBB2_BREAST_TUMORS_324_DN | 9.02e-04 | 151 | 8 | 2 | M8901 | |
| Coexpression | LANDIS_ERBB2_BREAST_TUMORS_324_DN | 9.75e-04 | 157 | 8 | 2 | MM1099 | |
| Coexpression | GSE25088_CTRL_VS_ROSIGLITAZONE_STIM_MACROPHAGE_DN | 1.35e-03 | 185 | 8 | 2 | M8010 | |
| Coexpression | GSE26928_NAIVE_VS_CENT_MEMORY_CD4_TCELL_UP | 1.45e-03 | 192 | 8 | 2 | M4677 | |
| Coexpression | GSE1460_NAIVE_CD4_TCELL_CORD_BLOOD_VS_THYMIC_STROMAL_CELL_UP | 1.47e-03 | 193 | 8 | 2 | M3484 | |
| Coexpression | GSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_NFATC1_KO_8H_DN | 1.54e-03 | 198 | 8 | 2 | M8274 | |
| Coexpression | GSE24634_IL4_VS_CTRL_TREATED_NAIVE_CD4_TCELL_DAY10_UP | 1.54e-03 | 198 | 8 | 2 | M4639 | |
| Coexpression | GSE28783_ANTI_MIR33_VS_UNTREATED_ATHEROSCLEROSIS_MACROPHAGE_UP | 1.56e-03 | 199 | 8 | 2 | M8351 | |
| Coexpression | GSE21546_SAP1A_KO_VS_SAP1A_KO_AND_ELK1_KO_DP_THYMOCYTES_DN | 1.56e-03 | 199 | 8 | 2 | M7524 | |
| Coexpression | GSE17721_0.5H_VS_8H_GARDIQUIMOD_BMDC_DN | 1.56e-03 | 199 | 8 | 2 | M4142 | |
| Coexpression | GSE13485_PRE_VS_POST_YF17D_VACCINATION_PBMC_DN | 1.56e-03 | 199 | 8 | 2 | M3311 | |
| Coexpression | GSE41867_LCMV_ARMSTRONG_VS_CLONE13_DAY15_EFFECTOR_CD8_TCELL_UP | 1.57e-03 | 200 | 8 | 2 | M9522 | |
| Coexpression | GSE29164_UNTREATED_VS_CD8_TCELL_AND_IL12_TREATED_MELANOMA_DAY3_UP | 1.57e-03 | 200 | 8 | 2 | M8484 | |
| Coexpression | GSE15735_CTRL_VS_HDAC_INHIBITOR_TREATED_CD4_TCELL_12H_DN | 1.57e-03 | 200 | 8 | 2 | M7157 | |
| Coexpression | KAECH_NAIVE_VS_DAY15_EFF_CD8_TCELL_UP | 1.57e-03 | 200 | 8 | 2 | M3014 | |
| Coexpression | KAECH_DAY15_EFF_VS_MEMORY_CD8_TCELL_DN | 1.57e-03 | 200 | 8 | 2 | M3032 | |
| Coexpression | GSE18893_CTRL_VS_TNF_TREATED_TCONV_2H_DN | 1.57e-03 | 200 | 8 | 2 | M7302 | |
| Coexpression | GSE16385_UNTREATED_VS_12H_ROSIGLITAZONE_IL4_TREATED_MACROPHAGE_DN | 1.57e-03 | 200 | 8 | 2 | M7913 | |
| Coexpression | GSE3982_NEUTROPHIL_VS_CENT_MEMORY_CD4_TCELL_DN | 1.57e-03 | 200 | 8 | 2 | M5529 | |
| Coexpression | GSE21927_BALBC_VS_C57BL6_MONOCYTE_TUMOR_UP | 1.57e-03 | 200 | 8 | 2 | M7606 | |
| Coexpression | GSE22919_RESTING_VS_IL2_IL12_IL15_STIM_NK_CELL_DN | 1.57e-03 | 200 | 8 | 2 | M7836 | |
| Coexpression | KYNG_DNA_DAMAGE_UP | 1.65e-03 | 205 | 8 | 2 | M3961 | |
| ToppCell | TCGA-Thryoid-Primary_Tumor-Thyroid_Papillary_Carcinoma-Follicular-8|TCGA-Thryoid / Sample_Type by Project: Shred V9 | 2.12e-04 | 125 | 8 | 2 | 519a474238e370fe2a8b51460c28b39c1b01c0c9 | |
| ToppCell | LPS_only-Hematopoietic_Erythro-Megakary-Erythro-Mega-Platelets|LPS_only / Treatment groups by lineage, cell group, cell type | 2.58e-04 | 138 | 8 | 2 | 6ddd50e44a3914596b4cd61ae64a987119fe7979 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.51e-04 | 161 | 8 | 2 | 5fba13f0aa5002f7eefe219e2c6a07e163f1a50d | |
| ToppCell | facs-Trachea-24m-Mesenchymal-fibroblast-fibroblast_of_trachea-|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.15e-04 | 175 | 8 | 2 | bb898796662b97f7459b7dda7cecf6a9bde8b055 | |
| ToppCell | facs-Trachea-24m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l32-30|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.78e-04 | 188 | 8 | 2 | c2febf9fd4632af1f922067c3a30e5c50f75f480 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.89e-04 | 190 | 8 | 2 | ae97df1b06bcd46c05759b53c35dc8fea97f4ac1 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.94e-04 | 191 | 8 | 2 | 2b056cbe2e82e056e1f798974999378460eb1d16 | |
| ToppCell | Tracheal-10x3prime_v2-Stromal-Schwann|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 5.36e-04 | 199 | 8 | 2 | 8dc65662c3ca1db2ba0091332f0658abc0afc5de | |
| ToppCell | Tracheal-10x3prime_v2-Stromal-Schwann-Schwann_nonmyelinating|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 5.36e-04 | 199 | 8 | 2 | a92718a3f1153b8d2196fd343ed5bc0ebc98cad7 | |
| Disease | eye color | 2.55e-04 | 90 | 8 | 2 | EFO_0003949 | |
| Disease | glaucoma | 7.42e-04 | 154 | 8 | 2 | MONDO_0005041 | |
| Disease | Parkinson disease | 3.16e-03 | 321 | 8 | 2 | MONDO_0005180 | |
| Disease | retinal vasculature measurement | 8.00e-03 | 517 | 8 | 2 | EFO_0010554 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GPKGEKGANGKRGKM | 166 | Q6ZMI3 | |
| CRDMKKFGGPGRMKQ | 56 | Q6PCT2 | |
| KLGRGGSDGCKVPMK | 4176 | O95714 | |
| PVMIKAVRGGGGKGM | 201 | Q96RQ3 | |
| KRLGPGCGMMAGGKK | 406 | Q96EB1 | |
| KMGKGYLPCGMPGSG | 371 | P27987 | |
| GCGKKSPFGGLGTMK | 606 | O15417 | |
| RKGGCAKGKGGSMHM | 141 | P08559 |